Antitumor Effect of (131)I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer

Anaplastic thyroid cancer (ATC) comprises approximately 2% of all thyroid cancers, and its median survival rate remains poor because of its resistance to conventional therapy. Vascular endothelial growth factor receptor (VEGFR)-targeted therapeutics-loaded mesoporous silica nanoparticles represent a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruiguo, Zhang, Yueqian, Tan, Jian, Wang, Hanjie, Zhang, Guizhi, Li, Ning, Meng, Zhaowei, Zhang, Fuhai, Chang, Jin, Wang, Renfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Nano Express
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419646/
https://www.ncbi.nlm.nih.gov/pubmed/30874973
http://dx.doi.org/10.1186/s11671-019-2924-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419646/
https://www.ncbi.nlm.nih.gov/pubmed/30874973
http://dx.doi.org/10.1186/s11671-019-2924-z

Ejemplares similares